Artificial intelligence is becoming an important part of the pharmaceutical sector. It is being used in research, drug development, clinical trials, manufacturing and regulatory work. A McKinsey study ...

The Air Force has issued guidance on how transgender Airmen and Guardians will be involuntarily discharged, making it the ...

The upcoming Clinical Trials in Rare Diseases conference will cover the most concerning challenges in rare disease research.

In this episode presented by Cresset, BioSpace’s head of insights Lori Ellis discusses clinical trial fail rates and AI’s potential to reduce preclinical costs with Mutlu Dogruel, VP of AI and Mark ...

When bad news drops, investors have a tendency to sell first and ask questions later. Let's take a closer look at why Viking ...

Kimberly (Cary) Demirhan, a registered nurse and assistant director of Education Programs at the Association of Cancer Care Centers (ACCC), sat down for an interview with CURE to discuss the need for ...

The company plans to continue with a lower dose and a change in the pre-treatment regimen after a trial participant died ...

More than two years after the Food and Drug Administration held a public workshop on measuring overall survival (OS) in ...